Unknown

Dataset Information

0

Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.


ABSTRACT: Epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial transition (MET) are central to metastatic aggressiveness and therapy resistance in solid tumors. While molecular determinants of both processes have been extensively characterized, the heterogeneity in the response of tumor cells to EMT and MET inducers has come into focus recently, and has been implicated in the failure of anti-cancer therapies. Recent experimental studies have shown that some cells can undergo an irreversible EMT depending on the duration of exposure to EMT-inducing signals. While the irreversibility of MET, or equivalently, resistance to EMT, has not been studied in as much detail, evidence supporting such behavior is slowly emerging. Here, we identify two possible mechanisms that can underlie resistance of cells to undergo EMT: epigenetic feedback in ZEB1/GRHL2 feedback loop and stochastic partitioning of biomolecules during cell division. Identifying the ZEB1/GRHL2 axis as a key determinant of epithelial-mesenchymal plasticity across many cancer types, we use mechanistic mathematical models to show how GRHL2 can be involved in both the abovementioned processes, thus driving an irreversible MET. Our study highlights how an isogenic population may contain subpopulation with varying degrees of susceptibility or resistance to EMT, and proposes a next set of questions for detailed experimental studies characterizing the irreversibility of MET/resistance to EMT.

SUBMITTER: Jia W 

PROVIDER: S-EPMC7343638 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.

Jia Wen W   Tripathi Shubham S   Chakraborty Priyanka P   Chedere Adithya A   Rangarajan Annapoorni A   Levine Herbert H   Jolly Mohit Kumar MK  

Oncotarget 20200707 27


Epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial transition (MET) are central to metastatic aggressiveness and therapy resistance in solid tumors. While molecular determinants of both processes have been extensively characterized, the heterogeneity in the response of tumor cells to EMT and MET inducers has come into focus recently, and has been implicated in the failure of anti-cancer therapies. Recent experimental studies have shown that some cells can unde  ...[more]

Similar Datasets

| S-EPMC3511357 | biostudies-literature
| S-EPMC4932973 | biostudies-literature
| S-EPMC3169110 | biostudies-literature
| S-EPMC5914505 | biostudies-literature
| S-EPMC3375158 | biostudies-literature
| S-EPMC4960620 | biostudies-literature
2018-05-09 | GSE105486 | GEO
| S-EPMC6501681 | biostudies-literature
| S-EPMC3049411 | biostudies-literature
| S-EPMC2953149 | biostudies-literature